Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated

How Common Are Breast Fibroadenomas in Teens and Adults?

At a Glance

Breast fibroadenomas are most common from ages 15 to 35 and may become more noticeable during pregnancy or breastfeeding. A confirmed fibroadenoma is benign, but every new lump needs age-appropriate evaluation, especially after menopause or with rapid growth or skin or nipple changes.

Breast fibroadenomas are one of the most common benign (non-cancerous) breast tumors. If you are between the ages of 15 and 35 and have discovered a lump, a fibroadenoma is a highly typical diagnosis for your age group [1][2]. The most important thing to know is that a confirmed fibroadenoma is benign and does not turn into breast cancer.

Because fibroadenomas are hormonally responsive, their growth and prevalence are closely tied to the reproductive stages of life for women and people with breast tissue. While they can occur at almost any age, the likelihood of developing a new one shifts over time.

Prevalence by Age

  • Teenagers and Young Adults (Ages 15–35): This is the peak age range for developing fibroadenomas [1][2]. Because many of these lumps are small and painless, people often have them without realizing it. In one screening study of women aged 18 to 40 in South China, routine ultrasound imaging detected fibroadenomas in over 1 in 4 participants (27.6%) [3]. This statistic included very small, unnoticeable lesions, demonstrating just how frequently they occur in this age bracket.
  • During Pregnancy and Lactation: Fibroadenomas may grow or become more noticeable during pregnancy due to hormonal changes [4]. However, a new or persistent lump during pregnancy or breastfeeding should never be ignored or assumed to be just a harmless hormone change. It requires timely medical evaluation to rule out other conditions, including a lactating adenoma or, rarely, pregnancy-associated breast cancer [5].
  • Older Adults and Postmenopause: Developing a new fibroadenoma is quite uncommon after menopause [6]. If a postmenopausal person discovers a new breast lump, it is statistically less likely to be a fibroadenoma and requires careful diagnostic evaluation [6].

How Age Guides the Evaluation

Age helps doctors understand the statistical likelihood of a lump being a fibroadenoma, but it never replaces the need for a physical examination and medical imaging. Every new lump must be evaluated, but your age is used as a general starting point to determine which imaging tests are used first [7]:

  • Under Age 30 (and during pregnancy/lactation): An ultrasound (imaging that uses sound waves) is generally the preferred first test [7][8]. Younger breast tissue tends to be dense, and ultrasound is highly effective at evaluating lumps in dense tissue [9].
  • Ages 30 to 39: Depending on your history and the physical examination, doctors may start with an ultrasound, a diagnostic mammogram, or both [7].
  • Age 40 and Older: A diagnostic mammogram (specialized breast X-rays used to investigate a symptom), typically combined with a targeted ultrasound, is the standard approach [7][9]. The two tests provide complementary information, helping clinicians get a complete picture of the breast tissue.

Monitoring vs. Biopsy

If your physical examination and imaging results both clearly point to a benign fibroadenoma (meaning the findings are “concordant”), your doctor might reassure you and recommend a period of short-term monitoring with follow-up imaging rather than an immediate procedure [7][10].

However, doctors will recommend a core needle biopsy (a procedure that uses a small needle to remove a tissue sample for lab testing) if the imaging is suspicious, or if the clinical examination does not match the imaging results [8][11]. A biopsy is the only way to definitively confirm the diagnosis.

When to Seek Prompt Attention
Regardless of your age, some symptoms warrant immediate evaluation and potential biopsy to rule out breast cancer or a phyllodes tumor (a rare tumor that can mimic a fibroadenoma but sometimes requires surgical removal) [12][13][14]. Contact your doctor if you notice:

  • Rapid growth of the lump [12]
  • Skin dimpling, puckering, or thickening [9]
  • Nipple changes, such as new retraction, inversion, or bloody discharge [9]
  • A new lump in your armpit

Common questions in this guide

How common are fibroadenomas in teenagers and young adults?
They are among the most common benign breast tumors and are especially common from ages 15 to 35. Many are small and painless, so a person may have one without knowing it.
Can pregnancy or breastfeeding make a fibroadenoma more noticeable?
Yes. Hormonal changes can make a fibroadenoma grow or become easier to feel during pregnancy or breastfeeding. Any new or persistent lump in this setting should be examined rather than assumed to be a fibroadenoma.
Is a new fibroadenoma common after menopause?
No. A new fibroadenoma is uncommon after menopause, so a new lump then needs careful diagnostic evaluation. Imaging and sometimes a tissue sample help determine the cause.
What breast imaging is usually used at different ages?
For people under 30 and during pregnancy or breastfeeding, ultrasound is generally the first test. From 30 to 39, a clinician may recommend ultrasound, a diagnostic mammogram, or both; at age 40 and older, a diagnostic mammogram with targeted ultrasound is generally used.
If a lump looks like a fibroadenoma, do I still need a biopsy?
Not always. If the examination and imaging both clearly suggest a benign fibroadenoma, short-term follow-up imaging may be an option. A core needle biopsy is recommended when imaging is suspicious or the examination does not fit the imaging, and it is the definitive way to confirm the diagnosis.
What changes in a breast lump should prompt medical attention?
Rapid growth, skin dimpling or thickening, new nipple inversion or retraction, bloody discharge, or a new armpit lump should be checked promptly. Any new breast lump deserves medical evaluation regardless of age.
Can a confirmed fibroadenoma turn into breast cancer?
A confirmed fibroadenoma is benign and does not turn into breast cancer. However, a new or changing lump may not be a fibroadenoma, so it should be evaluated rather than assumed to be harmless.

Get notified when new evidence is published on breast fibroadenoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Case report: Axilla fibroadenoma - An atypical presentation.

    Virji SN, Vohra LM, Abidi SS, Idrees R

    Annals of medicine and surgery (2012) 2022; (80()):104295 doi:10.1016/j.amsu.2022.104295.

    PMID: 36045822
  2. 2

    Giant fibroadenoma with massive infarction masquerading as malignancy: a case report.

    Singh SK, Gupta P, Arora R, et al.

    International cancer conference journal 2017; (6(4)):167-170 doi:10.1007/s13691-017-0299-5.

    PMID: 31149495
  3. 3

    Prevalence of breast fibroadenoma in healthy physical examination population in Guangdong province of China: a cross-sectional study.

    Zhu L, Zeng X, Jiang S, et al.

    BMJ open 2022; (12(6)):e057080 doi:10.1136/bmjopen-2021-057080.

    PMID: 35760543
  4. 4

    Giant breast fibroadenoma in pregnancy.

    Krhovský Miroslav, Pilka Radovan, Fait Vuk, Eim Josef

    Ceska gynekologie 2021; (86(2)):114-117 doi:10.48095/cccg2021114.

    PMID: 34020558
  5. 5

    Imaging of Lactating Adenoma: Differential Diagnosis of Solid Mass Lesion in a Lactating Woman.

    Ravikanth R, Kamalasekar K

    Journal of medical ultrasound 2019; (27(4)):208-210 doi:10.4103/JMU.JMU_3_19.

    PMID: 31867197
  6. 6

    Fibroadenoma With Multiple Epidermal Inclusion Cysts Masquerading as Malignancy: An Underreported Entity With Review of Literature.

    Spoorthy Rekha YC, Ramachandra Rao RK, Sandeep S, Vivek TG

    International journal of surgical pathology 2025; (33(3)):753-756 doi:10.1177/10668969241283487.

    PMID: 39350750
  7. 7

    ACR Appropriateness Criteria Palpable Breast Masses.

    Harvey JA, Mahoney MC, Newell MS, et al.

    Journal of the American College of Radiology : JACR 2016; (13(11S)):e31-e42 doi:10.1016/j.jacr.2016.09.022.

    PMID: 27814822
  8. 8

    Common Breast Problems.

    Salzman B, Collins E, Hersh L

    American family physician 2019; (99(8)):505-514.

    PMID: 30990294
  9. 9

    [Exploring a non-inflammatory clinical breast mass: Clinical practice guidelines].

    Legendre G, Guilhen N, Nadeau C, et al.

    Journal de gynecologie, obstetrique et biologie de la reproduction 2015; (44(10)):904-12.

    PMID: 26541562
  10. 10

    False-negative rate of combined mammography and ultrasound for women with palpable breast masses.

    Chan CH, Coopey SB, Freer PE, Hughes KS

    Breast cancer research and treatment 2015; (153(3)):699-702 doi:10.1007/s10549-015-3557-2.

    PMID: 26341750
  11. 11

    Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors - short text.

    Lavoué V, Fritel X, Antoine M, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2016; (200()):16-23.

    PMID: 26967341
  12. 12

    Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised?

    Lee A, James J, Whisker L, et al.

    Annals of the Royal College of Surgeons of England 2022; (104(5)):361-366 doi:10.1308/rcsann.2021.0208.

    PMID: 34939848
  13. 13

    Can Radiologist and Pathologist Reach The Truth Together in The Diagnosis of Benign Fibroepithelial Lesions?

    Durhan G, Önder Ö, Azizova A, et al.

    European journal of breast health 2019; (15(3)):176-182 doi:10.5152/ejbh.2019.4656.

    PMID: 31312794
  14. 14

    American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions.

    Rosenberger LH, White RL, Tafra L, et al.

    JAMA surgery 2025; (160(12)):1378-1385 doi:10.1001/jamasurg.2025.4392.

    PMID: 41123921

This page is for informational purposes only and is not medical advice. It explains how age affects the likelihood and evaluation of a breast fibroadenoma; a new, changing, or persistent breast lump should be assessed by a healthcare professional.